Patient characteristics
| Patient no., age/sex . | Stage . | Lesion character . | Previous therapy . | Drug dose, % . | Best response (SWAT) . | No. of adverse events . |
|---|---|---|---|---|---|---|
| 1 70 y/M | IB | Folliculotropic plaque | Interferon α, Aldara cream, Tazorac cream, nitrogen mustard ointment, IFN-γ, Clobetasol cream, PUVA, Carmustine ointment, Bexarotene capsules, intralesional Kenalog, total skin electron beam radiation | 0.06 | Partial | Fever, skin erosion |
| 2 77 y/M | IB | Patch, plaque | Topical steroids, Aldara cream, nitrogen mustard ointment, topical carmustine, narrow-band UVB, PUVA, total skin electron beam radiation, IFN-α | 0.06 | Partial | Skin erosion, headache |
| 3 68 y/M | IB | Patch, plaque | Clobetasol, IFN-α, tazarotene cream, Aldara, Aclovate cream, Bexarotene capsules, Bexarotene gel, nitrogen mustard ointment, narrow-band UVB, PUVA, electron beam radiation | 0.06 | Complete | Fever, skin erosion |
| 4 75 y/M | IIA | Patch | IFN-α, nitrogen mustard ointment, Clobetasol cream, hydrocortisone cream | 0.06 | Partial | Skin irritation |
| 5 41 y/M | IA | Folliculotropic patch | Carmustine ointment, Clobetasol cream, Imiquimod 3.75% gel | 0.06 | Stable disease | |
| 6 63 y/M | IB | Folliculotropic patch | Bexarotene gel, Bexarotene capsules, IFN-α, narrow-band UVB, nitrogen mustard ointment, Carmustine ointment, tazarotene cream, Imiquimod 3.75%, Halobetasol cream | 0.06 | Partial | Skin erosion |
| 7 33 y/F | IB | Patch | Narrow-band UVB, nitrogen mustard ointment, cortisone creams (multiple) | 0.06 | Partial | |
| 8 51 y/M | IB | Folliculotropic patch | Betamethasone dipropionate, Carmustine ointment, Triamcinolone cream, PUVA | 0.06 | Complete | Headache, myalgias |
| 9 70 y/M | IB | Patch | Clobetasol cream, IFN-α, nitrogen mustard ointment | 0.03 | Partial | Skin irritation |
| 10 65 y/F | IB | Patch | Carmustine ointment, nitrogen mustard ointment, PUVA, narrow-band UVB, topical steroids (multiple) | 0.03 | Partial | |
| 11 63y/F | IB | Folliculotropic plaque | Clobetasol cream, nitrogen mustard ointment, Carmustine ointment, IFN-α, IFN-γ, Aldara, PUVA, Tazorac cream, local electron beam radiation | 0.03 | Partial | |
| 12 25 y/F | IB | Patch | PUVA, nitrogen mustard ointment, narrow-band UVB, Bexarotene capsules, Bexarotene gel, Carmustine ointment, IFN-γ, IFN-α | 0.03 | Partial | Skin irritation |
| Patient no., age/sex . | Stage . | Lesion character . | Previous therapy . | Drug dose, % . | Best response (SWAT) . | No. of adverse events . |
|---|---|---|---|---|---|---|
| 1 70 y/M | IB | Folliculotropic plaque | Interferon α, Aldara cream, Tazorac cream, nitrogen mustard ointment, IFN-γ, Clobetasol cream, PUVA, Carmustine ointment, Bexarotene capsules, intralesional Kenalog, total skin electron beam radiation | 0.06 | Partial | Fever, skin erosion |
| 2 77 y/M | IB | Patch, plaque | Topical steroids, Aldara cream, nitrogen mustard ointment, topical carmustine, narrow-band UVB, PUVA, total skin electron beam radiation, IFN-α | 0.06 | Partial | Skin erosion, headache |
| 3 68 y/M | IB | Patch, plaque | Clobetasol, IFN-α, tazarotene cream, Aldara, Aclovate cream, Bexarotene capsules, Bexarotene gel, nitrogen mustard ointment, narrow-band UVB, PUVA, electron beam radiation | 0.06 | Complete | Fever, skin erosion |
| 4 75 y/M | IIA | Patch | IFN-α, nitrogen mustard ointment, Clobetasol cream, hydrocortisone cream | 0.06 | Partial | Skin irritation |
| 5 41 y/M | IA | Folliculotropic patch | Carmustine ointment, Clobetasol cream, Imiquimod 3.75% gel | 0.06 | Stable disease | |
| 6 63 y/M | IB | Folliculotropic patch | Bexarotene gel, Bexarotene capsules, IFN-α, narrow-band UVB, nitrogen mustard ointment, Carmustine ointment, tazarotene cream, Imiquimod 3.75%, Halobetasol cream | 0.06 | Partial | Skin erosion |
| 7 33 y/F | IB | Patch | Narrow-band UVB, nitrogen mustard ointment, cortisone creams (multiple) | 0.06 | Partial | |
| 8 51 y/M | IB | Folliculotropic patch | Betamethasone dipropionate, Carmustine ointment, Triamcinolone cream, PUVA | 0.06 | Complete | Headache, myalgias |
| 9 70 y/M | IB | Patch | Clobetasol cream, IFN-α, nitrogen mustard ointment | 0.03 | Partial | Skin irritation |
| 10 65 y/F | IB | Patch | Carmustine ointment, nitrogen mustard ointment, PUVA, narrow-band UVB, topical steroids (multiple) | 0.03 | Partial | |
| 11 63y/F | IB | Folliculotropic plaque | Clobetasol cream, nitrogen mustard ointment, Carmustine ointment, IFN-α, IFN-γ, Aldara, PUVA, Tazorac cream, local electron beam radiation | 0.03 | Partial | |
| 12 25 y/F | IB | Patch | PUVA, nitrogen mustard ointment, narrow-band UVB, Bexarotene capsules, Bexarotene gel, Carmustine ointment, IFN-γ, IFN-α | 0.03 | Partial | Skin irritation |
PUVA, psoralen and UVA therapy.